Table 2. Binding of monoclonal anti- CB2 antibodyNAA-1 to surface-immobilized CB2.
Running Buffer | Source of protein | Protein immobilized | Treatment after immobilization | Running Buffer | Antibody binding (%) |
---|---|---|---|---|---|
TBS-T | Homogeneous preparation | CB2 | none | TBS-T | 64% |
TBS-T | Cell Iyzate | Fusion | none | TBS-T | 20% |
C-SPR | Cell Iyzate | Fusion | none | C-SPR | 2% |
C-SPR | Cell Iyzate | Fusion | TEV protease cleavage | C-SPR | 60% |